Revelation Biosciences Inc (REVB)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $2.43M
Last updated: Nov 17, 2026 at 4:25 PM ET
Revelation Biosciences Inc (REVB) Stock Chart
Revelation Biosciences (REVB) has a latest price of $3.90 on Nov 17, 2026, 43.7% below its 52-week high of $6.93. Its price fell 84.5% over the past 12 months. The month-end price fell 100.0% over the 5 years through Oct 2026, a compound annual decline of 95.1%.
Price Chart
From Nov 2020 to Oct 2026, its highest month-end close was $14,461,922.51 in Feb 2021 and its lowest $4.03 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart REVB with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for REVB.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 49.8%, and over 6 months it fell 45.9%. The month-end price fell 100.0% over the 3 years through Oct 2026, a compound annual decline of 94.5%.
| Period | Change |
|---|---|
| 1 month | +18.7% |
| 3 months | -49.8% |
| 6 months | -45.9% |
| 12 months | -84.5% |
| 12 months, with dividends | -84.5% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -100.0% | -94.5% |
| 5 years | -100.0% | -95.1% |
Price by Year
Its best calendar year was 2021, when the price rose 1.5%, and its weakest was 2022, when it fell 98.1%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $4.03 | -82.0% |
| 2025 | $22.39 | -96.4% |
| 2024 | $619.46 | -96.9% |
| 2023 | $20,204.39 | -92.5% |
| 2022 | $268,215.75 | -98.1% |
| 2021 | $14,391,376.55 | +1.5% |
Trading Range
The price is 22.5% below its 50-day average of $5.03 and 46.3% below its 200-day average of $7.26.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $3.90 | |
| 52-week high | $6.93 | -43.7% |
| 52-week low | $0.47 | +735.1% |
| 50-day average | $5.03 | -22.5% |
| 200-day average | $7.26 | -46.3% |
Price Risk
Over 3 years, its largest fall from a peak was 100.0%.
| Measure | Value |
|---|---|
| 1-year beta | 1.70 |
| Largest fall, 1 year | -89.8% |
| Largest fall, 3 years | -100.0% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About REVB
What is REVB's 1-year price change?
Revelation Biosciences's price fell 84.5% over the past 12 months. With dividends included, the 12-month total return was -84.5%.
What is REVB's 5-year price change?
Revelation Biosciences's month-end price fell 100.0% over the 5 years through Oct 2026, a compound annual decline of 95.1%. These figures leave out dividends.
What is REVB's 52-week high and low?
Revelation Biosciences's 52-week high is $6.93 and its 52-week low is $0.47. Its latest price of $3.90 on Nov 17, 2026 is 43.7% below the high.
What is REVB's beta?
Revelation Biosciences's 1-year beta against the S&P 500 is 1.70, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 89.8%.
Is the REVB chart free?
Yes. Advanced Charting for REVB is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
REVB pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors